INSTRUCTIONS Hidradenitis suppurativa: A clinician's tool for early diagnosis and treatment
* To take the test online, go to our secure Web site at http://www.nursingcenter.com/ce/NP.
* On the print form, record your answers in the test answer section of the CE enrollment form on page 29. Each question has only one correct answer. You may make copies of these forms.
* Complete the registration information and course evaluation. Mail the completed form and registration fee of $21.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
* You will receive your CE certificate of earned contact hours and an answer key to review your results.There is no minimum passing grade.
* Registration deadline is May 31, 2012.
DISCOUNTS and CUSTOMER SERVICE
* Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together and deduct $0.95 from the price of each test.
* We also offer CE accounts for hospitals and other healthcare facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of The Nurse Practitioner journal, will award 2.0 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.0 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Hidradenitis suppurativa: A clinician's tool for early diagnosis and treatment
General Purpose: To familiarize NPs with the diagnosis and treatment of HS. Learning Objectives: After reading the previous article and taking the following test, the NP will be able to: 1. Discuss the pathophysiology and prevalence of HS. 2. Describe the diagnostic process for HS. 3. Identify treatment options for HS.
1. HS lesions usually occur near which glands?
2. HS lesions are most likely to be found in which area?
3. HS is sometimes associated with
a. pilonidal sinuses.
b. acne rosacea.
4. HS primarily affects
a. preadolescent children.
b. older adults.
5. Where would HS prevalence probably be higher?
6. In men, HS most often occurs in which area of the body?
a. anogenital region
d. periumbilical area
7. Which age falls within the peak range for HS onset?
a. 9 years
b. 32 years
c. 51 years
d. 66 years
8. Predisposing factors of HS include
b. poor hygiene.
9. Compared with the general population, the mortality associated with HS is
b. the same.
d. significantly higher.
10. Recent studies suggest that HS is caused by
a. stratum corneum malfunction.
b. apocrine gland infection.
c. apocrine gland occlusion.
d. follicular occlusion.
11. Early HS lesions are usually
b. bridged comedones.
12. Which of the following is the hallmark finding of HS?
b. infected lesions
c. bridged comedones
13. Diagnosis usually does not include
a. positive biopsy.
b. typical lesions.
c. characteristic lesion distribution.
14. The first clinical stage is usually associated with
b. surgical intervention.
c. isolated lesions.
d. sinus tracts.
15. Initial treatment includes
a. cool compresses.
b. incision and drainage.
c. intravenous antibiotics.
d. intralesional corticosteroid injections.
16. An antibiotic commonly used in early HS is
17. Which drug would most likely be recommended for pain?
d. oxycodone with acetaminophen
18. The most effective curative therapy for third stage HS is
a. incision and drainage.
b. silver-impregnated dressings.
c. tumor necrosis factor blockers.
d. radical surgery.
© 2010 Lippincott Williams & Wilkins, Inc.